New Blood Test Shows 96% Accuracy in Diagnosing ME/CFS

Published 2 days ago

story

Image copyright:

The Spin

This revolutionary blood test represents a monumental breakthrough for ME/CFS patients who have suffered for decades without proper diagnostic tools. The EpiSwitch technology delivers an unprecedented 96% accuracy rate, finally providing concrete biological evidence that validates this debilitating condition and offers hope to millions worldwide.

Bioengineer.org

This study's impressive claims fall apart under scrutiny — it only tested severe, housebound patients against perfectly healthy controls, ignoring those with similar conditions like depression or fibromyalgia. The 96% accuracy figure is misleading statistical hype that could drop to just 73% in real-world applications.

Science Media Centre